Evidence map›Paper›PMID 41969428›Full record

ArticleNeuro-oncology advances

Radiomics-based preoperative survival prediction in newly diagnosed glioblastoma: A multicohort study with internal and external validation.

Toru Umehara, Manabu Kinoshita, Takahiro Sasaki, Junya Fukai, Ema Yoshioka, Daisuke Sakamoto, Kosuke Nakajo, Koji Takano, Hideyuki Arita, Chisato Yokota and 5 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Toru UmeharaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.ORCID https://orcid.org/0000-0001-5904-4882
Manabu KinoshitaDepartment of Neurosurgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.ORCID https://orcid.org/0000-0001-7923-6902
Takahiro SasakiDepartment of Neurological Surgery, School of Medicine, Wakayama Medical University, Wakayama, Wakayama, Japan.
Junya FukaiDepartment of Neurological Surgery, School of Medicine, Wakayama Medical University, Wakayama, Wakayama, Japan.
Ema YoshiokaDivision of Molecular Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.
Daisuke SakamotoDepartment of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Kosuke NakajoDepartment of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Koji TakanoDepartment of Neurosurgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.
Hideyuki AritaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Chisato YokotaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Ryuichi HirayamaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Noriyuki KijimaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yoshiko OkitaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Haruhiko KishimaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yonehiro KanemuraDivision of Molecular Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Preoperative survival prediction in newly diagnosed glioblastoma (nGBM) remains challenging due to limited robustness and standardization across radiomic approaches. We aimed to validate a machine learning-based prognostic model using preoperative MR images and assess its generalizability. Methods: Two independent cohorts were analyzed: the Kansai Molecular Diagnosis Network for CNS Tumors (KNBTG) and The Cancer Genome Atlas (TCGA). All cases with available preoperative MR images (T1WI, T2WI, and Gd-T1WI) were included. The KNBTG cohort was divided into a training dataset (TD, Results: Radiomic high-risk status was associated with significantly shorter OS in both ITD and ETD (log-rank Conclusions: Radiomics-based modeling provides reproducible prognostic value in nGBM. The feature "T2_core_GLCMhomogeniety_3_SD" may serve as a reliable imaging biomarker for preoperative risk stratification and individualized treatment planning.

Indexed as

glioblastomamachine learningradiomicssurvival prediction

Identifiers

PMID41969428
PMCPMC13063838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.